Implementation of preemptive DNA sequence-based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study.

MLA

Wang, Liewei, et al. “Implementation of Preemptive DNA Sequence-Based Pharmacogenomics Testing across a Large Academic Medical Center: The Mayo-Baylor RIGHT 10K Study.” Genetics in Medicine : Official Journal of the American College of Medical Genetics, vol. 24, no. 5, May 2022, pp. 1062–72. EBSCOhost, https://doi.org/10.1016/j.gim.2022.01.022.

APA

Wang, L., Scherer, S. E., Bielinski, S. J., Muzny, D. M., Jones, L. A., Black, J. L., 3rd, Moyer, A. M., Giri, J., Sharp, R. R., Matey, E. T., Wright, J. A., Oyen, L. J., Nicholson, W. T., Wiepert, M., Sullard, T., Curry, T. B., Rohrer Vitek, C. R., McAllister, T. M., St Sauver, J. L., … Weinshilboum, R. M. (2022). Implementation of preemptive DNA sequence-based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study. Genetics in Medicine : Official Journal of the American College of Medical Genetics, 24(5), 1062–1072. https://doi.org/10.1016/j.gim.2022.01.022

Chicago

Wang, Liewei, Steven E Scherer, Suzette J Bielinski, Donna M Muzny, Leila A Jones, John Logan Black 3rd, Ann M Moyer, et al. 2022. “Implementation of Preemptive DNA Sequence-Based Pharmacogenomics Testing across a Large Academic Medical Center: The Mayo-Baylor RIGHT 10K Study.” Genetics in Medicine : Official Journal of the American College of Medical Genetics 24 (5): 1062–72. doi:10.1016/j.gim.2022.01.022.